HeartBeam, Inc.
HeartBeam, Inc.
- Market cap
- $6.65M
Your view on BEATW
Overview
What the company does, where it operates, and who runs it.
About HeartBeam, Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Branislav Vajdic
- Headquarters
- 2118 Walsh Avenue, Santa Clara, CA, US
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Branislav Vajdic
- Headquarters
- 2118 Walsh Avenue, Santa Clara, CA, US
HeartBeam, Inc. is an emerging enterprise concentrating on innovative cardiovascular diagnostic technology. The company has developed an electrocardiogram (ECG) collection device specifically designed to gather critical heart health data from patients remotely.
This system enables medical professionals to access vital diagnostic insights even when the patient is outside a traditional clinical setting. ECG readings are transmitted wirelessly from the device to a patient's smartphone, which then relays this information to a sophisticated, cloud-based expert software system for analysis.
Branislav Vajdic established this Santa Clara, California-headquartered company in 2015.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for HeartBeam, Inc.. Starting points for HeartBeam, Inc.: EPS -$0.32, beta 0.85 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for HeartBeam, Inc.. Trailing twelve-month EPS for HeartBeam, Inc. stands at -$0.32. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for HeartBeam, Inc.. HeartBeam, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SSMXFSysmex Corporation | Healthcare | OTC | $5.4B | ||
| SSMXYSysmex Corporation | Healthcare | OTC | $5.5B | ||
| STESTERIS plc | Healthcare | NYSE | $25.2B | ||
| TRIBTrinity Biotech plc | Healthcare | NASDAQ | $118.0M | ||
| UAHCUnited American Healthcare Corporation | Healthcare | OTC | $1.1M | ||
| UEECUnited Health Products, Inc. | Healthcare | OTC | $14.9M | ||
| VFY.AXVitrafy Life Sciences Ltd. | Healthcare | ASX | — | ||
| VMTHFVenus Medtech (Hangzhou) Inc. | Healthcare | OTC | $184.7M | ||
| VVVVvVARDIS HOLDING AG Class A | Healthcare | NYSE | $597.1M | ||
| WCUIWellness Center USA, Inc. | Healthcare | OTC | $13,063 | ||
| WOKWORK Medical Technology Group Ltd. | Healthcare | NASDAQ | $5.1M | ||
| YPHDFYpsomed Holding AG | Healthcare | OTC | $5.2B | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by HeartBeam, Inc. executives and directors. Shares of HeartBeam, Inc. have traded between $0.01 and $0.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for HeartBeam, Inc.. Coverage tracks HeartBeam, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of HeartBeam, Inc.